Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Define tax-managed index funds, their benefits for tax efficiency, and how they fit into a retirement investment plan.
16,789 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
NovaBridge Crypto cuts 12% of its workforce to accelerate its AI strategy, signaling a wider shift toward AI-driven e...
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
Three durable businesses stand out for a buy-and-hold approach as markets adjust to AI-driven demand and steadier gro...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Gold prices slide as liquidity fades and risk appetite shifts, forcing traders to rethink the king of safe havens and...
In a volatile stretch for investors, Tesla’s AI chip plant plans sparked a rally in the stock market today, march. Th...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...